<DOC>
	<DOCNO>NCT02158195</DOCNO>
	<brief_summary>The aim study compare different blood cell immune response patient Autoimmune Hemolytic Anemia healthy subject . Evaluate impact treatment , notably corticoid , blood cell immune response . Better understanding mechanism involve course disease could lead new treatment . 12 patient Autoimmune Hemolytic Anemia compare 12 control match sex age . Controls provide blood sample . The particular follow-up . Patients provide blood sample time diagnosis 3 month start treatment . If new treatment need start end 3-month period , new blood sample take .</brief_summary>
	<brief_title>Immunopathology Autoimmune Hemolytic Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Hemolysis</mesh_term>
	<mesh_term>Anemia , Hemolytic</mesh_term>
	<mesh_term>Anemia , Hemolytic , Autoimmune</mesh_term>
	<criteria>Patients diagnose primary warm Autoimmune Hemolytic Anemia Secondary Autoimmune Hemolytic Anemia ( infection , hemopathy , systemic disease ) Naive treatment hemolytic anemia relapse Older 16 year age Able understand write spoken French provide write informed consent â€¢ INCLUSION CRITERIA CONTROLS Persons without autoimmune disease , cancer active infection . Older 16 year age Able understand write spoken French provide write informed consent Cold agglutinin disease Pregnant woman Persons cover national health insurance NonInclusion Criteria control : Persons treat corticoid immunosuppressant Pregnant woman Persons cover national health insurance</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>